1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer

EMBO welcomes 55 leading life scientists as members


Heidelberg, Germany, 9 May 2012 – Fifty-five life scientists from Europe and around the world were today recognised by EMBO for their excellence in research. Forty-eight of the researchers are from Europe and neighbouring countries while seven scientists from Argentina, Australia, South Korea and the United States join as Associate Members. In total, EMBO membership now comprises almost 1,550 life scientists in the international scientific community.



EMBO elects new members annually on the basis of scientific excellence. The new members represent a broad cross-section of the life sciences. The latest scientists to join the group come from 17 different countries and include 13 female scientists recognized for their contributions to life science research.


The new nominees include the first ever Associate Members in South Korea and Argentina. "Our members are the basis for the excellent international reputation of EMBO and its increasingly global orientation. We welcome this group of exceptional scientists and look forward to their fresh input and ideas," said EMBO Director Maria Leptin.


The selected researchers will help shape the direction of the life sciences in Europe and beyond by their involvement with the activities of the organization. EMBO Members provide scientific input such as acting on advisory editorial boards of the four scientific journals of the organization, serving on selection committees for EMBO Programmes and giving general advice to the scientific community.


A list of all new EMBO Members and Associate Members accompanies this announcement.



Name Institute Country
Ronen Alon Weizmann Institute of Science, Rehovot IL
Rolf Apweiler European Bioinformatics Institute, Hinxton, Cambridge GB
Manuela Baccarini Max F. Perutz Laboratories, University of Vienna AT
Shankar Balasubramanian University of Cambridge GB
Cosima T. Baldari University of Siena IT
Lucia Banci University of Florence, Sesto Fiorentino IT
Axel Behrens Cancer Research UK, London Research Institute GB
Monsef Benkirane CNRS Institute of Human Genetics, Montpellier FR
Ewan Birney European Bioinformatics Institute, Hinxton, Cambridge GB
Cédric Blanpain Free University of Brussels BE
Jannie Borst Netherlands Cancer Institute, Amsterdam NL
Paola Bovolenta Nicolao Centre for Molecular Biology 'Severo Ochoa', Madrid ES
Jens C. Brüning University of Cologne DE
Francesco Cecconi University 'Tor Vergata' and
IRCCS Fondazione Santa Lucia, Rome
Jane Clarke University of Cambridge GB
Fabrizio d'Adda di Fagagna IFOM – European Institute of Oncology, Milan IT
Ulrike Gaul Ludwig Maximilians University, Munich DE
Pascal Genschik CNRS IBMP, University of Strasbourg FR
Urs Greber University of Zurich CH
William A. Harris University of Cambridge GB
Urs Jenal Biozentrum, University of Basel CH
Torben Heick Jensen Aarhus University DK
Ludger Johannes Institut Curie, Paris FR
Kai Johnsson Swiss Federal Institute of Technology, Lausanne CH
Jos M.M. Jonkers Netherlands Cancer Institute, Amsterdam NL
Stefan H.E. Kaufmann Max-Planck Institute for Infection Biology, Berlin DE
Michel Labouesse Institute of Genetics and Molecular and Cellular Biology, Illkirch FR
Andreas Ladurner Ludwig Maximilians University, Munich DE
Nils-Göran Larsson Max Planck Institute for Biology of Ageing, Cologne DE
Andreas Lüthi Friedrich Miescher Institute, Basel CH
Laura Machesky Beatson Institute for Cancer Research, Glasgow GB
Paul Martin University of Bristol GB
William Martin Heinrich Heine University, Düsseldorf DE
Rául Méndez Institute for Research in Biomedicine, Barcelona ES
Eric Miska Gurdon Institute, University of Cambridge GB
May-Britt Moser Kavli Institute for Systems Neuroscience, Trondheim NO
Béla Novák University of Oxford GB
Nancy Papalopulu University of Manchester GB
Chris Ponting University of Oxford, MRC GB
Thomas Preat ESPCI ParisTech, Paris FR
Michael Sattler Technical University of Munich, Garching and
Helmholtz Zentrum München, Neuherberg
François Schweisguth Institut Pasteur, Paris FR
Luca Scorrano University of Geneva CH
Maria Sibilia Institute of Cancer Research, Medical University of Vienna AT
Thomas Surrey Cancer Research UK, London Research Institute GB
Sarah A. Teichmann MRC Laboratory of Molecular Biology, Cambridge GB
Antoine Triller Institute of Biology of the ENS, Paris FR
Sabine Werner Institute of Molecular Health Sciences, Zurich CH



Name Institute Country
Vishva Dixit Genentech, South San Francisco US
V. Narry Kim Seoul National University KR
Alberto R. Kornblihtt University of Buenos Aires AR
Eric S. Lander Broad Institute of MIT and Harvard, Cambridge US
Ruth Lehmann

NYU School of Medicine, HHMI Fellow

Ronald D. Vale University of California San Francisco US
David L. Vaux Walter and Eliza Hall Institute, Parkville AU



This email address is being protected from spambots. You need JavaScript enabled to view it.


Tilmann KießlingTilmann Kießling
Head, Communications
T. + 49 160 9019 3839